Market Place
Sourcing Support
Liquid Botulinum Toxin Type A Gets FDA IND Approval
25 Sep 2024 //
PR NEWSWIRE
Evolus Introduces Nuceiva® In Australia
30 Jul 2024 //
BUSINESSWIRE
Evexta Bio Appoints Shawn M. Leland As Chairman
19 Jun 2024 //
BUSINESSWIRE
Evolus Launches Nuceiva In Spain Broadening International Presence
12 Jun 2024 //
BUSINESSWIRE
Ipsen`s Biologic Dysport (AbobotulinumtoxinA) Receives Approval in the U.S.
21 Sep 2023 //
FDA
Daewoong’s botulinum toxin wins `world’s 1st` nod to treat square jaw
28 Aug 2023 //
KOREA BIOMED
AEON Receives Notice of Allowance for a Patent Covering Use of Botulinum Toxins
24 Aug 2023 //
GLOBENEWSWIRE
Medytox`s BTX patent could face invalidation trial in US
04 Mar 2023 //
KOREAHERALD
Ipsen` Biologic DYSPORT (AbobotulinumtoxinA) Receives Approval in the U.S.
12 Jan 2023 //
FDA
Hugel resubmits BLA for botulinum toxin, Botulax to US FDA
08 Oct 2022 //
PHARMABIZ
Aeon hits phase 2 goals in rare disorder
24 Sep 2022 //
FIERCEBIOTECH
Galderma posts phase 3 wins for botulinum toxin A on path to FDA
15 Jun 2022 //
FIERCEPHARMA
DelNova Advances ReViVox to Reverse Botulinum Toxin Neuromodulator Complications
01 Apr 2022 //
PRNEWSWIRE
Aquavit Files IND with FDA for DTX-021, a New Botulinum Toxin
24 Mar 2022 //
PRNEWSWIRE
Botox rival Jeuveau`s star is rising, Evolus said Friday
05 Mar 2022 //
FIERCEPHARMA
Healis Therapeutics acquires ownership of key botulinum toxin patent
10 Feb 2022 //
PRNEWSWIRE
Medytox`s Patent Suit Against Daewoong Dismissed in U.S.
07 Oct 2021 //
YNA
Medytox may market its BTX product through Evolus`
09 Sep 2021 //
KOREABIOMED
Eirion Therapeutics Announces Strategic Agreement for HTL Biotechnology
08 Sep 2021 //
PRNEWSWIRE
New analyses of pivotal PhIII trial data highlight long of response for Dysport®
14 Jan 2021 //
BUSINESSWIRE
Galderma Announces Top-line Results from Phase 2 Clinical Dose-Escalating Study
17 Nov 2020 //
PRNEWSWIRE
Allergan`s Biological Onabotulinumtoxina Receives Approval In US
17 Sep 2020 //
FDA
Botox for TMJ disorders may not lead to bone loss in the short term
15 Sep 2020 //
EUREKALERT
Ipsen Announces Updated Indication for Dysport® (abobotulinumtoxinA)
10 Jul 2020 //
BIOSPACE
Croma-Pharma announces submission for their botulinum toxin to treat glabellar
08 Jul 2020 //
BUSINESSWIRE
Thailand recalls Medytox’s botulinum toxin
20 May 2020 //
KOREABIOMED
Korea bans local sales of Medytox’s BTX drug Meditoxin
21 Apr 2020 //
KOREAHERALD
Botox gets license update in UK
26 Mar 2020 //
PHARMATIMES
Medytox, Daewoong may seek out of court settlement over botox originality
02 Mar 2020 //
PULSENEWS
MHRA updates Dysport license to include upper limb spasticity in children
06 Jan 2020 //
PHARMA TIMES
Ipsen`s Dysport Effective in Treating Limb Spasticity
23 Sep 2019 //
BIOSPACE
AbbVie/Allergan`s merger faces public opposition
14 Sep 2019 //
PMLIVE
Hey, FTC, unions say: AbbVie-Allergan merger needs a close look
13 Sep 2019 //
FIERCE PHARMA
FDA Approves US WorldMeds` MYOBLOC® (rimabotulinumtoxinB) Injection
26 Aug 2019 //
PR NEWSWIRE
Botox rival, FDA inspections, Daiichi and more—FiercePharmaAsia
09 Aug 2019 //
FIERCE PHARMA
Allergan`s bid to shield Botox manufacturing secrets backfires
09 Aug 2019 //
FIERCE PHARMA
